Literature DB >> 879976

Platelet methylene reductase activity in schizophrenia.

P A Berger, G R Elliott, E Erdelyi, S J Watson, R J Wyatt, J D Barchas.   

Abstract

A case of a folate-responsive psychosis that was associated with a defect in N5-10-methylenetetrahydrofolate reductase (methylene reductase) suggested the need to examine whether abnormally low activity of this enzyme might be of etiological importance in schizophrenia. We now report that there were no statistically significant differences in the platelet methylene reductase activity of chronic schizophrenics, compared with either hospitalized or nonhospitalized age-matched control subjects. Although it is possible that a larger survey might reveal a subpopulation of schizophrenics who are characterized by abnormal methylene reductase activity, this study suggests that chronic schizophrenia is not generally associated with such changes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879976     DOI: 10.1001/archpsyc.1977.01770190070006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  2 in total

1.  Homocysteinemia is a common feature of schizophrenia.

Authors:  B Regland; B V Johansson; B Grenfeldt; L T Hjelmgren; M Medhus
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Homocysteinemia and schizophrenia as a case of methylation deficiency.

Authors:  B Regland; B V Johansson; C G Gottfries
Journal:  J Neural Transm Gen Sect       Date:  1994
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.